Agenus to participate in fireside chat at the b. riley fall 2021 growth biotech best ideas series

Lexington, mass., nov. 09, 2021 (globe newswire) -- agenus inc. (nasdaq: agen), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that dr. steven o'day, chief medical officer, and dr. dhan chand, scientific director, head of drug discovery at agenus, will participate in a fireside chat hosted by b. riley on monday, november 15, 2021 at 12:00 pm est. dr. o'day and dr. chand will discuss the agen1181 program (fc-enhanced ctla-4), following presentation of clinical data at the society for immunotherapy of cancer (sitc) 36th annual meeting on friday, november 12th, 2021.
AGEN Ratings Summary
AGEN Quant Ranking